UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:  000-28414

 

Urologix, Inc.
(Exact name of registrant as specified in its charter)
 
14405 21st Avenue North
Minneapolis, MN 55447
(612) 475-1400
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock
Series A Junior Participating Preferred Stock Purchase Rights
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

    Rule 12g-4(a)(1) ☒
    Rule 12g-4(a)(2) ☐
    Rule 12h-3(b)(1)(i) ☒
    Rule 12h-3(b)(1)(ii) ☐
    Rule 15d-6 ☒

 

Approximate number of holders of record as of the certification or notice date:    214              

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Urologix, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

DATE:  July 10, 2015 By:   /s/  Scott M. Madson
    Scott M. Madson
Chief Financial Officer

 

 

 

 

Urologix (CE) (USOTC:ULGX)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Urologix (CE) Charts.
Urologix (CE) (USOTC:ULGX)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Urologix (CE) Charts.